Gut microbe emerges as a promising tool in the fight against COVID-19
View as a Web Page
News Medical
 
  Bowel Cancer Bowel Cancer logo  
  The latest bowel cancer news from News Medical  
 Scientists develop tool to predict bowel cancer drug resistanceScientists develop tool to predict bowel cancer drug resistance
 
Scientists have developed a tool that can predict how bowel cancer adapts to treatment – helping researchers to design new personalized drugs that will keep patients living well for longer.
 
 
 Gut microbe emerges as a promising tool in the fight against COVID-19Gut microbe emerges as a promising tool in the fight against COVID-19
 
Researchers found that Akkermansia muciniphila boosts lung-specific antiviral immunity against SARS-CoV-2 in mice by modulating the gut–lung axis. This commensal gut bacterium shows promise as a potential biomarker and biotherapeutic candidate for COVID-19 and other respiratory infections.
 
   Understanding the interconnected roles of microbial, metabolic, and immune biomarkers in IBDUnderstanding the interconnected roles of microbial, metabolic, and immune biomarkers in IBD
 
Inflammatory Bowel Disease (IBD), encompassing ulcerative colitis (UC) and Crohn's disease (CD), is a chronic inflammatory condition of the gastrointestinal tract with a rising global burden.
 
   New KRAS mutation discovery opens door to targeted colon cancer therapiesNew KRAS mutation discovery opens door to targeted colon cancer therapies
 
Scientists at Fox Chase Cancer Center have identified a mutation in a common oncogene - a gene that can cause cancer - that may play an important role in colon cancer. Researchers also showed how this mutation could be targeted therapeutically.
 
 Targeting IGF2BP1 offers a new approach to cancer therapy
 
The RNA-binding protein IGF2BP1 has emerged as a key regulator of cancer hallmarks, influencing tumor proliferation, metastasis, immune evasion, and resistance to cell death.
 
 
 Exploring cytokine networks in autoimmune diseases and advances in therapy
 
Exploring cytokine networks in autoimmune diseases and advances in therapyThis article explores the complex roles of cytokine networks in the development and progression of autoimmune diseases.
 
 
 CIK treatment enhances survival in early and advanced colorectal cancer
 
CIK treatment enhances survival in early and advanced colorectal cancerColorectal cancer (CRC) is the second most common cause of death from cancer in the United States (US) and the most prevalent malignant tumor worldwide.
 
 
 Navigating IVD compliance with IVDR and Indian MDR standards
 
Navigating IVD compliance with IVDR and Indian MDR standardsLearn how in vitro diagnostic (IVD) devices can comply with IVDR and Indian MDR standards, ensuring regulatory alignment, safety, and market readiness.
 
 
 Low FODMAP diet shown to improve gastrointestinal symptoms in women with endometriosis
 
Low FODMAP diet shown to improve gastrointestinal symptoms in women with endometriosisA low FODMAP diet developed by Monash University researchers for irritable bowel syndrome (IBS) has been shown to improve gastrointestinal symptoms in women with endometriosis.
 
 
 How do genetics and diet shape the human microbiome?
 
How do genetics and diet shape the human microbiome?Discover how genetics and diet shape the human gut microbiome, influencing health, metabolism, and disease risk. Explore implications for precision nutrition.
 
 
 Missing gut bacteria in US babies triples allergy and eczema risk
 
Missing gut bacteria in US babies triples allergy and eczema riskUS infants lacking Bifidobacterium in their gut microbiome face significant changes in microbial composition, metabolic function, and immune-related health risks. This large, nationally representative study links early-life Bifidobacterium deficits to a three-fold increase in eczema, allergy, or asthma by age two.
 
 
 Organotypic model of the human gut epithelium demonstrates genetic determinants of Shigella colonization
 
Organotypic model of the human gut epithelium demonstrates genetic determinants of Shigella colonizationA study in Nature Genetics uses organotypic gut models to reveal genome-wide genetic determinants of Shigella colonization, spotlighting type III secretion system effectors as crucial for early infection.
 
 
 Do genetic variants that affect DNA methylation influence colorectal cancer risk or outcomes?
 
Do genetic variants that affect DNA methylation influence colorectal cancer risk or outcomes?The study identifies genetic variants influencing colorectal cancer risk through DNA methylation, suggesting new avenues for targeted screening and prevention.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025